Publicacións en colaboración con investigadores/as de Hospital Universitario La Fe (47)

2023

  1. Alpha-cardiac Actin Serum Expression Levels Detect Acute Cellular Rejection in Heart Transplant Patients

    Transplantation, Vol. 107, Núm. 2, pp. 466-474

  2. Altered MicroRNA Maturation in Ischemic Hearts: Implication of Hypoxia on XPO5 and DICER1 Dysregulation and RedoximiR State

    Antioxidants, Vol. 12, Núm. 7

  3. Combining Serum miR-144-3p and miR-652-3p as Potential Biomarkers for the Early Diagnosis and Stratification of Acute Cellular Rejection in Heart Transplantation Patients

    Transplantation, Vol. 107, Núm. 9, pp. 2064-2072

2022

  1. Diagnostic value of serum miR-144-3p for the detection of acute cellular rejection in heart transplant patients

    Journal of Heart and Lung Transplantation, Vol. 41, Núm. 2, pp. 137-147

  2. Role of Sodium-Glucose Co-Transporter 2 Inhibitors in the Regulation of Inflammatory Processes in Animal Models

    International Journal of Molecular Sciences, Vol. 23, Núm. 10

  3. The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile

    Frontiers in Pharmacology, Vol. 13

2021

  1. Circulating mitochondrial genes detect acute cardiac allograft rejection: Role of the mitochondrial calcium uniporter complex

    American Journal of Transplantation, Vol. 21, Núm. 6, pp. 2056-2066

2020

  1. Adipokines and inflammation: Focus on cardiovascular diseases

    International Journal of Molecular Sciences, Vol. 21, Núm. 20, pp. 1-34

  2. Plasma CD5L and non-invasive diagnosis of acute heart rejection

    Journal of Heart and Lung Transplantation, Vol. 39, Núm. 3, pp. 257-266

  3. XPO1 Gene Therapy Attenuates Cardiac Dysfunction in Rats with Chronic Induced Myocardial Infarction

    Journal of Cardiovascular Translational Research, Vol. 13, Núm. 4, pp. 593-600

2019

  1. Circulating Sphingosine-1-Phosphate as A Non-Invasive Biomarker of Heart Transplant Rejection

    Scientific reports, Vol. 9, Núm. 1, pp. 13880

  2. Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving autophagy in the hearts of Zucker diabetic fatty rats

    Biochemical Pharmacology, Vol. 170

  3. The altered expression of autophagy-related genes participates in heart failure: NRBP2 and CALCOCO2 are associated with left ventricular dysfunction parameters in human dilated cardiomyopathy

    PLoS ONE, Vol. 14, Núm. 4

2018

  1. ASB1 differential methylation in ischaemic cardiomyopathy: Relationship with left ventricular performance in end-stage heart failure patients

    ESC Heart Failure, Vol. 5, Núm. 4, pp. 732-737

  2. Myocardium of patients with dilated cardiomyopathy presents altered expression of genes involved in thyroid hormone biosynthesis

    PLoS ONE, Vol. 13, Núm. 1

2017

  1. Changes in human Golgi apparatus reflect new left ventricular dimensions and function in dilated cardiomyopathy patients

    European Journal of Heart Failure

  2. Intercalated disc in failing hearts from patients with dilated cardiomyopathy: Its role in the depressed left ventricular function

    PLoS ONE, Vol. 12, Núm. 9

  3. Relaxin-2 in cardiometabolic diseases: Mechanisms of action and future perspectives

    Frontiers in Physiology, Vol. 8, Núm. AUG

  4. SERCA2a: A potential non-invasive biomarker of cardiac allograft rejection

    Journal of Heart and Lung Transplantation, Vol. 36, Núm. 12, pp. 1322-1328

  5. Thyroid hormone biosynthesis machinery is altered in the ischemic myocardium: An epigenomic study

    International Journal of Cardiology, Vol. 243, pp. 27-33